Véronique Debien, Medical Oncologist at Institute Bergonié, shared a post on LinkedIn:
“Interested in early Drug Development and Precision Oncology?
Applications are now open for the ESMO – European Society for Medical Oncology Leadership and Career Development Award fellowship.
Our center, Institute Bergonié in Bordeaux, France 🇫🇷 , part of the Unicancer network and the EURACAN rare cancer network, is pleased to host a fellow within our Early Phase Clinical Trials Unit.
What the fellowship offers:
- Hands-on experience in early-phase clinical trials (FIH to phase II).
- Exposure to precision oncology and molecular tumor boards.
- Participation in innovative drug development (immunotherapy, ADCs, targeted therapies).
Our unit runs ~70 early-phase trials and treats ~300 patients/year, contributing to the development of transformative cancer therapies.
This training environment aligns with the ESMO Roadmap 2030, promoting responsible innovation and precision oncology. Thank you to ESMO – European Society for Medical Oncology for supporting the training of future oncology leaders.
- Applications are now open.
- Deadline: Sunday, May 3
- More information.
Please feel free to share with colleagues or trainees interested in clinical research and early drug development in oncology.”
Other articles about ESMO on OncoDaily.